KYMR

Q: What is the price of Kymera Therapeutics (KYMR) today?

The current price of Kymera Therapeutics (KYMR) is $ 86.93, representing a 234.73% gain over the past year. The stock began the year trading around $ 77.81 and is currently priced at $ 86.93. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Kymera Therapeutics (KYMR) pay dividends?

Kymera Therapeutics (KYMR) did not pay dividends over the past year.

Kymera Therapeutics Inc.

Price

$ 86.93

return (12m)

234.73%

p/e

-25.35

p/bv

5.00

DIVIDEND YIELD

0.00%

KYMR price

KYMR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment KYMR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.58%

3 months

27.58%

1 year

234.73%

2 years

155.90%

5 years

118.47%

10 years

0.00%

Fundamentals KYMR

review the fundamentals of Kymera Therapeutics shares

P/E

-25.35

Sector: -4.11 Industry: -4.11

P/S (PSR)

201.32

Sector: -3.78 Industry: -3.78

P/BV

5.00

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-17.86%

Sector: -61.23% Industry: -61.23%

ROE

-19.71%

Sector: -60.44% Industry: -60.44%

ROIC

-51.53%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

-100.00%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

100.00%

Sector: 37.92% Industry: 37.92%

OPERATING MARGIN

-100.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

-26.08

Sector: -4.00 Industry: -4.00

EV/EBIT

-25.38

Sector: -4.22 Industry: -4.22

PRICE-TO-ASSETS

4.53

Sector: 1.44 Industry: 1.44

BVPS

17.55

Sector: 1.88 Industry: 1.88

EPS

-3.46

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.91

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.09

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

-11.65%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

25.45%

Sector: - Industry: -

Fundamentals KYMR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.93	7.08	33.81%	2.23%	$ 560.91 B	28.46%
PFE	20.17	1.68	8.35%	6.24%	$ 156.71 B	12.42%
ABBV	87.13	0.00	0.00%	3.19%	$ 368.21 B	6.91%
NVO	11.49	5.92	51.50%	4.60%	$ 179.95 B	33.05%
MRK	16.19	0.00	0.00%	2.79%	$ 295.53 B	28.08%
AZN	31.07	6.52	20.99%	1.56%	$ 317.64 B	17.41%
GILD	20.09	7.56	37.62%	2.32%	$ 170.95 B	28.90%
BMY	17.19	-3.56	-20.72%	4.18%	$ 121.26 B	14.64%
ZTS	20.05	16.09	80.25%	1.66%	$ 53.60 B	28.23%
REGN	17.16	2.47	14.41%	0.48%	$ 77.31 B	31.41%
HALO	25.80	167.51	649.21%	0.00%	$ 8.18 B	22.69%
AMGN	24.84	22.12	89.06%	2.72%	$ 191.51 B	20.98%
MCK	24.55	-1,076.41	-4,383.84%	0.37%	$ 106.56 B	1.09%
VRTX	28.35	6.00	21.18%	0.00%	$ 112.06 B	32.94%
CAH	30.39	-18.70	-61.56%	0.95%	$ 50.50 B	0.68%
HRMY	10.77	1.96	18.24%	0.00%	$ 1.71 B	18.27%
ADMA	17.83	5.49	30.78%	0.00%	$ 2.62 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

KYMR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kymera Therapeutics

Kymera Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

75

Employees

Kymera Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.89 Billions, with shareholders equity totaling $1.58 Billion.

The company employs approximately 75 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kymera Therapeutics Inc. reported $39.21 Millions in revenue, generating net income of $-311.34 Millions.

Key financial metrics include a P/E ratio of -25.35, a price-to-book (P/B) ratio of 5.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KYMR.

Market cap

$ 7.89 Billions

Net worth

$ 1.58 Billion

$ 1,579,660,000.00

Assets

$ 1.74 Billion

$ 1,742,810,000.00

Total Shares Outstanding

90.00 Millions

90,000,000

Average Daily Trading Volume

$ 728.63 Thousand

$ 728,632.06

Sector

Health Care

Industry

Biotechnology

KYMR

KYMR revenue and profits

Financial Results KYMR

DRAG THE FRAME TO SEE MORE DATA

KYMR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 859.04 26,37% (12M)

P/E

24.55

0.37%

ROE

-4,383.84%

P/BV

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12M)

P/E

20.93

2.23%

ROE

33.81%

P/BV

7.08

PFE - Pfizer

$ 27.52 33,93% (12M)

P/E

20.17

6.24%

ROE

8.35%

P/BV

1.68

ABBV - AbbVie

$ 203.71 24,66% (12M)

P/E

87.13

3.19%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12M)

P/E

16.19

2.79%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12M)

P/E

31.07

1.56%

ROE

20.99%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 859.04 26,37% (12 M)

P/L

24.55

0.37%

ROE

-4,383.84%

P/VP

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12 M)

P/L

20.93

2.23%

ROE

33.81%

P/VP

7.08

PFE - Pfizer

$ 27.52 33,93% (12 M)

P/L

20.17

6.24%

ROE

8.35%

P/VP

1.68

ABBV - AbbVie

$ 203.71 24,66% (12 M)

P/L

87.13

3.19%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12 M)

P/L

16.19

2.79%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12 M)

P/L

31.07

1.56%

ROE

20.99%

P/VP

6.52

Frequently Asked Questions

What is the price of Kymera Therapeutics (KYMR) today?

The current price of Kymera Therapeutics (KYMR) is $ 86.93, representing a 234.73% gain over the past year. The stock began the year trading around $ 77.81 and is currently priced at $ 86.93. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kymera Therapeutics (KYMR) pay dividends?

Kymera Therapeutics (KYMR) did not pay dividends over the past year.

Is Kymera Therapeutics (KYMR) a good investment?

Kymera Therapeutics (KYMR) is currently trading at $ 86.93 with a P/E ratio of -25.35%. This represents a -1,443% premium compared to its historical average P/E. Over the past year, the stock has gained 234.73 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 234.73%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kymera Therapeutics (KYMR) stock?

You can buy Kymera Therapeutics (KYMR) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KYMR and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kymera Therapeutics (KYMR) yield today?

Over the past month, Kymera Therapeutics (KYMR) has returned 11.58% — 234.73% over the past year, and 118.47% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Kymera Therapeutics (KYMR) today at the current price of $ 86.93 your total investment would be $ 8,693.00.

Based on historical performance, the investment would have grown to approximately:

$ 29,098.08 after 1 year
$ 18,991.60 after 5 years
$ 8,693.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KYMR

Kymera Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KYMR

review the fundamentals of Kymera Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kymera Therapeutics

Kymera Therapeutics Inc.

United States

11 years

2020

75

PROFIT X PRICE KYMR

Financial Results KYMR

KYMR cash flow

Asset, Revenue and Profit Growth - KYMR

KYMR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions